223 related articles for article (PubMed ID: 7719417)
21. Etiology of fulminant viral hepatitis in Greece.
Papaevangelou G; Tassopoulos N; Roumeliotou-Karayannis A; Richardson C
Hepatology; 1984; 4(3):369-72. PubMed ID: 6327484
[TBL] [Abstract][Full Text] [Related]
22. Viral hepatitis: a pathologic spectrum.
Peters RL
Am J Med Sci; 1975; 270(1):17-31. PubMed ID: 171949
[TBL] [Abstract][Full Text] [Related]
23. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
[TBL] [Abstract][Full Text] [Related]
24. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.
Yoshiba M; Sekiyama K; Iwamura Y; Sugata F
Dig Dis Sci; 1993 Mar; 38(3):469-76. PubMed ID: 8444078
[TBL] [Abstract][Full Text] [Related]
25. [Partial parenteral nutrition in severe virus hepatitis].
Kleinberger G; Schneeweiss B; Druml W; Laggner A; Lenz K
Leber Magen Darm; 1984 Mar; 14(2):78-82. PubMed ID: 6438423
[TBL] [Abstract][Full Text] [Related]
26. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
[TBL] [Abstract][Full Text] [Related]
27. [A case of fulminant hepatitis E treated with artificial liver support].
Fujiyama Y; Yamagishi Y; Kikuchi M; Shimoji K; Kato S; Nagata H; Saito H; Hibi T; Mishiro S
Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):219-25. PubMed ID: 17283417
[TBL] [Abstract][Full Text] [Related]
28. Aetiology of icteric hepatitis and fulminant hepatic failure in children and the possible predisposition to hepatic failure by sickle cell disease.
Yohannan MD; Arif M; Ramia S
Acta Paediatr Scand; 1990 Feb; 79(2):201-5. PubMed ID: 2157327
[TBL] [Abstract][Full Text] [Related]
29. Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis.
Funaoka M; Kato K; Komatsu M; Ono T; Hoshino T; Kato J; Kuramitsu T; Ishii T; Toyoshima I; Masamune O
J Gastroenterol; 1996 Feb; 31(1):119-22. PubMed ID: 8808440
[TBL] [Abstract][Full Text] [Related]
30. Histopatological findings of the liver before and during hepatic coma in fulminant hepatitis.
Shimizu M; Yoshida T; Ohnishi H; Tomita E; Muto Y; Takahashi Y
Gastroenterol Jpn; 1982; 17(4):353-9. PubMed ID: 7141200
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.
Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E
Am J Gastroenterol; 1990 Jan; 85(1):24-9. PubMed ID: 1688684
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
33. [Fulminant hepatitis in children].
Durand P; Debray D; Devictor D
Presse Med; 1996 Oct; 25(31):1501-6. PubMed ID: 8958881
[TBL] [Abstract][Full Text] [Related]
34. Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method.
Fukai K; Yokosuka O; Fujiwara K; Tagawa M; Imazeki F; Saisho H; Omata M
J Infect Dis; 1998 Aug; 178(2):325-33. PubMed ID: 9697711
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study.
Sallie R; Silva AE; Purdy M; Smith H; McCaustland K; Tibbs C; Portmann B; Eddleston A; Bradley D; Williams R
J Hepatol; 1994 May; 20(5):580-8. PubMed ID: 8071532
[TBL] [Abstract][Full Text] [Related]
36. [A close association of prognosis with effect of interferon in HBV carriers developing acute severe exacervation].
Higuchi D; Sekiyama K; Yoshiba M; Inoue K; Fujita R
Nihon Shokakibyo Gakkai Zasshi; 1998 Sep; 95(9):1001-7. PubMed ID: 9785889
[TBL] [Abstract][Full Text] [Related]
37. Fulminant hepatic failure with massive necrosis as a result of hepatitis A infection.
Masada CT; Shaw BW; Zetterman RK; Kaufman SS; Markin RS
J Clin Gastroenterol; 1993 Sep; 17(2):158-62. PubMed ID: 8409320
[TBL] [Abstract][Full Text] [Related]
38. [An unusual form of a pulmonary fat embolism in fulminant viral hepatitis].
Schulz F; Püschel K
Pathologe; 1996 Mar; 17(2):154-6. PubMed ID: 8650146
[TBL] [Abstract][Full Text] [Related]
39. Fulminant viral hepatitis.
Pappas SC
Gastroenterol Clin North Am; 1995 Mar; 24(1):161-73. PubMed ID: 7729859
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
Acharya SK; Dasarathy S; Irshad M
J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
